Helicobacter pylori may be an initiating factor in newly diagnosed ulcerative colitis patients: A pilot study

Table 6 Erythrocyte sedimentation rate, C reactive protein, number of motions per day in the Helicobacter pylori treated and placebo group at baseline and after 2 wk of treatment

	H. pylori treated (n = 9)			Placebo (n = 8)
Parameters	Baseline	After 2 wk	P-value	Baseline	After 2 wk	P-value
ESR (1st)	38.56 ± 9.81	22.33 ± 5.55	< 0.001	37.50 ± 7.82	32.75 ± 6.34	0.203
ESR (2nd)	64 (54.25-73.25)	32 (30.5-37.5)	< 0.001	65.63 ± 11.51	58.75 ± 9.33	0.211
CRP	24 (22.5-36)	12 (6-12)	0.001	25.75 ± 9.29	24.12 ± 9.68	0.737
No. of motions per day	8 (6.75-9)	3 (2-3.25)	< 0.001	7.63 ± 1.41	6.88 ± 1.64	0.343

Data are presented as median (interquartile range) or mean and standard deviation. CRP: C reactive protein; ESR: Erythrocyte sedimentation rate.